Trump Announces 100% Tariff On Pharmaceutical Drugs’ Manufacturers Not Building Plants In US

Last Updated:September 26, 2025, 06:56 IST

Donald Trump announced that from October 1, 2025, all imported branded or patented drugs will face a 100% tariff unless manufacturers are building plants in the US.

A photo of US President Donald Trump (AP)

Donald Trump on Friday announced that all branded or patented drugs imported into the United States will face a 100 per cent tariff starting October 1, 2025, unless their manufacturers are building facilities in the country.

“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump wrote on his social media platform Truth Social.

He further clarified that “IS BUILDING” will be defined as ‘breaking ground’ and/or ‘under construction’. There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”

A day before, the US President had said he will put import taxes of 50 per cent on kitchen cabinets and bathroom vanities, 30 per cent on upholstered furniture and 25 per cent on heavy trucks starting October 1.

While Trump did not provide a legal justification for the tariffs, he stated on Truth Social that the taxes on imported kitchen cabinets and sofas were needed “for National Security and other reasons”.

Trump has long maintained that tariffs are the key to forcing companies to invest more in domestic factories.

He has dismissed fears that importers would pass along much of the cost of the taxes to consumers and businesses in the form of higher prices.

The President continues to claim that inflation is no longer a challenge for the US economy, despite evidence to the contrary. In the US, the consumer price index has increased 2.9 per cent over the past 12 months, up from an annual pace of 2.3 per cent in April, when Trump first launched a sweeping set of import taxes.

In 2024, America imported nearly $233 billion in pharmaceutical and medicinal products, the Associated Press quoted the Census Bureau.

The new tariffs on cabinetry could further increase the costs for homebuilders at a time when many people seeking to buy a house feel priced out by the mix of housing shortages and high mortgage rates, AP said.

The report also quoted the National Association of Realtors as saying that there were signs of price pressures easing as sales listings increased 11.7 per cent in August from a year ago, but still the median price for an existing home was $422,600.

ALSO READ | ‘There Are No Winners’: UN On Rising Use Of Tariffs And Trade Barriers Between Major Economies

About the Author

Vani Mehrotra

Vani Mehrotra is the Deputy News Editor at News18.com. She has nearly 10 years of experience in both national and international news and has previously worked on multiple desks.

Vani Mehrotra is the Deputy News Editor at News18.com. She has nearly 10 years of experience in both national and international news and has previously worked on multiple desks.

Read More

Go to Source